Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Knowing when to choose cash back over points on credit cards can save you money. Learn the scenarios that favor cash back!
27,373 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Two frontier AI firms are tipped for 2026 IPOs, with lofty valuations and aggressive monetization bets, as markets we...
With rate-cut bets disappearing, traders pivot to potential rate hikes and Bitcoin’s role as a long-term hedge agains...
A landmark innovator, Ted Turner reshaped TV by launching CNN, expanding cable, and preserving Hollywood classics. Th...
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
Today’s energy-focused market action shows how volatile solar stocks can be when short-seller whispers collide with b...
Stock splits can create catalysts that spark momentum and attract new buyers. This guide explains how the stock-split...
Kraft Heinz trimmed guidance after a challenging quarter, McCormick posted steady growth with margin pressure, and Ho...
When a memory-stock rally hits the headlines, you want the real story behind the move. This guide explains why sandis...
Across software-as-a-service stocks, Wix has been a standout case of a dramatic pullback. This piece breaks down why ...
As infrastructure spending gears up, industrial activity is priming the market for a new leg higher. Here are three s...
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...